MOLLY KIDNER: Open Payments
NPI 1083035521 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 13 payments from 10 companies in 2025. Trend: 2023 $26 · 2024 $0 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| PFIZER INC. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Exact Sciences Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: Auvelity, NURTEC ODT, REXULTI, VRAYLAR, JOURNAVX, Ozempic, CAPLYTA, QULIPTA.
Industry payments across MI — which companies pay providers there.
